Bringing the Predictive Power of Artificial Intelligence to Health Care 

Bringing the Predictive Power of Artificial Intelligence to Health Care 

An important aspect of treating patients with conditions like diabetes and heart disease is helping them stay healthy outside of the hospital — before they to return to the doctor’s office with further complications. But…

Read More
Rejuvenated fibroblasts can recover the ability to contract

Rejuvenated fibroblasts can recover the ability to contract

Fibroblasts are the most common connective tissue cells. They produce the structural framework for animal tissues, synthesise the extracellular matrix and collagen, and play a critical role in wound healing. However, during the cellular aging…

Read More
New biomaterial has potential to repair damaged bone with lower risk of inflammation

New biomaterial has potential to repair damaged bone with lower risk of inflammation

Scientists at RCSI University of Medicine and Health Sciences have developed a new biomaterial that has the potential to accelerate bone regeneration by promoting an immune response that encourages repair and lowers the risk of…

Read More
Artificial Red Blood Cells to Carry Oxygen, Drugs, and Work as Biosensors

Artificial Red Blood Cells to Carry Oxygen, Drugs, and Work as Biosensors

Manufacturing artificial red blood cells may turn out to be significant in treating a number of diseases and conditions. This has been tried in the past by a number of teams, but some important functions were missing…

Read More
Using gene therapy to help the body to make its own cancer drugs

Using gene therapy to help the body to make its own cancer drugs

Imagine that we could instruct our bodies to make the drugs they need themselves. The gene technology that makes this possible is called mRNA therapy, which may become a major tool in the treatment of…

Read More
New research reveals challenges and missed opportunities for wearables in clinical trials

New research reveals challenges and missed opportunities for wearables in clinical trials

A ‘significant’ number of biopharma companies are not actively incorporating wearable technology into their clinical trials, according to a new study from the Life Science Strategy Group, which argues there is a missed opportunity. The…

Read More
New research into stem cell mutations could improve regenerative medicine

New research into stem cell mutations could improve regenerative medicine

Research from the University of Sheffield has given new insight into the cause of mutations in pluripotent stem cells and potential ways of stopping these mutations from occurring. The findings, published in Stem Cell Reports, show…

Read More
AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit

AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit

AstraZeneca has reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and the Netherlands, to supply up to 400 million doses of the University of Oxford’s COVID-19 vaccine, with deliveries…

Read More
Novavax, already a fundraising star, gins up another $200M for vaccine work

Novavax, already a fundraising star, gins up another $200M for vaccine work

Amid the race to develop a COVID-19 vaccine, Novavax has been busy fundraising and inking deals to prepare for a manufacturing scale-up. That work continued Monday with the company’s $200 million raise through a private…

Read More
New Technique Developed for Self-Assembling Nanostructures

New Technique Developed for Self-Assembling Nanostructures

A new technique has been developed by scientists at Carnegie Mellon University for self-assembling nanostructures with gamma-modified peptide nucleic acid (γPNA)—an artificial imitator of DNA. Such a process may have an impact on nanomanufacturing, and also on…

Read More